Tempest Therapeutics Inc
(TPST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,553 | 56,134 | 18,078 | 21,077 | 28,193 |
| Marketable Securities | 64,815 | 33,331 | 26,349 | 28,489 | 26,152 |
| TOTAL | $82,615 | $90,070 | $45,077 | $50,407 | $55,262 |
| Non-Current Assets | |||||
| PPE Net | 1,909 | 1,202 | 880 | 730 | 890 |
| Investments And Advances | 1,108 | 1,403 | 1,500 | 0 | 0 |
| Other Non-Current Assets | 197 | 88 | 88 | 88 | 88 |
| TOTAL | $3,214 | $2,693 | $2,468 | $818 | $978 |
| Total Assets | $85,829 | $92,763 | $47,545 | $51,225 | $56,240 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,408 | 1,943 | 1,654 | 791 | 216 |
| Accrued Expenses | 5,646 | 4,344 | 4,120 | 1,365 | 1,596 |
| TOTAL | $7,054 | $6,287 | $5,774 | $2,156 | $1,812 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 78 | 74 | 70 | 65 | 15 |
| TOTAL | $78 | $74 | $70 | $65 | $15 |
| Total Liabilities | $7,132 | $6,361 | $5,844 | $2,221 | $1,827 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8 | 8 | 6 | 6 | 6 |
| Common Shares | 24 | 23 | 18 | 17 | 17 |
| Retained earnings | -62,885 | -52,992 | -45,178 | -34,178 | -27,287 |
| Other shareholders' equity | -8 | -3 | 10 | 3 | -26 |
| TOTAL | $78,697 | $86,402 | $41,701 | $49,004 | $54,413 |
| Total Liabilities And Equity | $85,829 | $92,763 | $47,545 | $51,225 | $56,240 |